Clinical Pearls
Eleftherios Mamounas, MD, MPH, medical director, Comprehensive Breast Program, University of Florida Health Cancer Center, discusses locoregional recurrence and tailoring radiotherapy following neoadjuvant chemotherapy.
- Researchers are trying to understand whether the response and tumor subtype of patients treated with neoadjuvant chemotherapy can help to tailor the use of radiotherapy afterwards.
- Though the data from this analysis do not provide a definitive answer, they help researchers understand that these patients had low rates of recurrence and tailoring radiotherapy is possible. Trials are in progress to test this concept.
<<<
Back to the 2014 Breast Cancer Symposium conference page